MURPHY ANDREW J has a total of 11 patent applications. Its first patent ever was published in 1901. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, agriculture and measurement are CRYSTAL BIOSCIENCE INC, TRIANNI INC and GENPHARM INT.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Canada | 1 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Agriculture | |
#3 | Measurement | |
#4 | Pharmaceuticals | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Animal care | |
#3 | Microorganisms | |
#4 | Fermentation | |
#5 | Analysing materials | |
#6 | Medical preparations | |
#7 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Murphy Andrew J | 11 |
#2 | Yancopoulos George D | 7 |
#3 | Stevens Sean | 6 |
#4 | Macdonald Lynn | 6 |
#5 | Karow Margaret | 5 |
#6 | Economides Aris N | 2 |
#7 | Croll-Kalish Susan | 2 |
#8 | Shanker Y G | 2 |
#9 | Valenzuela David M | 2 |
#10 | Torres Richard | 2 |
Publication | Filing date | Title |
---|---|---|
US2006123502A1 | Assay methods for identifying RE2-like antagonists, methods of use, and non-human transgenic animals | |
US2006117396A1 | Assay methods for identifying modulators of OPSDL3 and transgenic knockouts | |
US2005250185A1 | OGH fusion polypeptides and therapeutic uses thereof | |
CA76633A | Valve device |